日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic value of kappa free light chain index in patients with primary progressive multiple sclerosis

kappa游离轻链指数在原发性进展型多发性硬化症患者中的预后价值

Schmidauer, Martin; Berek, Klaus; Auer, Michael; Bsteh, Gabriel; Cavalla, Paola; Di Pauli, Franziska; Di Filippo, Massimiliano; Deisenhammer, Florian; Emeršič, Andreja; Föttinger, Fabian; Gaetani, Lorenzo; Hassler, Michaela; Krajnc, Nik; Milosavljevic, Dejan; Ponleitner, Markus; Petersen, Thor; Presslauer, Stefan; Rosenstein, Igal; Rot, Uroš; Tørring, Caroline Winther; Vecchio, Domizia; Vercellino, Marco; Zrzavy, Tobias; Zinganell, Anne; Walde, Janette; Hegen, Harald

Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in Italy

意大利复发缓解型多发性硬化症皮下注射那他珠单抗的成本最小化分析和预算影响分析

Prosperini, Luca; Pradelli, Lorenzo; Santoni, Laura; Perini, Daria; Cottone, Salvatore; Vercellino, Marco

Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning

利用无监督机器学习识别多发性硬化症患者未满足需求的明确模式

Maida, Elisabetta; Abbadessa, Gianmarco; Cocco, Eleonora; Valentino, Paola; Lerede, Annalaura; Frau, Jessica; Miele, Giuseppina; Bile, Floriana; Vercellino, Marco; Patti, Francesco; Borriello, Giovanna; Cavalla, Paola; Sparaco, Maddalena; Lavorgna, Luigi; Bonavita, Simona

Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis - a multicentre study

kappa游离轻链指数在原发性进展型多发性硬化症患者诊断中的价值——一项多中心研究

Hegen, Harald; Berek, Klaus; Cavalla, Paola; Christiansen, Mikael; Emeršič, Andreja; Di Filippo, Massimiliano; Gaetani, Lorenzo; Hassler, Michaela; Leurs, Cyra; Milosavljevic, Dejan; van Pesch, Vincent; Petersen, Thor; Presslauer, Stefan; Rosenstein, Igal; Rot, Uroš; Schnabl, Christine; Teunissen, Charlotte; Vecchio, Domizia; Vercellino, Marco; Deisenhammer, Florian

SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control study

以SARS-CoV-2大流行为模型评估并发病毒感染与多发性硬化症疾病活动度之间的关系:一项倾向评分匹配病例对照研究

Vercellino, Marco; Bosa, Chiara; Alteno, Anastasia; Muccio, Francesco; Marasciulo, Stella; Garelli, Paola; Cavalla, Paola

Onset of multiple sclerosis in a patient on dupilumab therapy for atopic dermatitis: A case report

接受度普利尤单抗治疗特应性皮炎患者发生多发性硬化症:病例报告

Gelato, Federica; Mastorino, Luca; Cavalla, Paola; Quaglino, Pietro; Cavaliere, Giovanni; Vercellino, Marco; Bosa, Chiara; Inglese, Matilde; De Palma, Raffaele; Ortoncelli, Michela; Ribero, Simone

Impact of COVID-19 lockdown on progressive multiple sclerosis patients

新冠疫情封锁对进行性多发性硬化症患者的影响

Vercellino, Marco; Bosa, Chiara; Alteno, Anastasia; Schillaci, Valentina; Petracca, Manuel; Marasciulo, Stella; Cavalla, Paola

Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series

病例报告:接受奥瑞珠单抗治疗的多发性硬化症患者感染新冠肺炎:病例系列

De Mercanti, Stefania F; Vercellino, Marco; Bosa, Chiara; Alteno, Anastasia; Schillaci, Valentina; Clerico, Marinella; Cavalla, Paola

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab

基线 CD19 细胞计数可预测接受奥克瑞珠单抗治疗的多发性硬化症患者在 6 个月和 12 个月时的 B 细胞重建情况

Abbadessa, Gianmarco; Miele, Giuseppina; Cavalla, Paola; Valentino, Paola; Marfia, Girolama Alessandra; Signoriello, Elisabetta; Landi, Doriana; Bosa, Chiara; Vercellino, Marco; De Martino, Antonio; Missione, Rosanna; Sparaco, Maddalena; Lavorgna, Luigi; Lus, Giacomo; Bonavita, Simona

Inhibition of Human Neutrophil Functions In Vitro by Multiple Sclerosis Disease-Modifying Therapies.

多发性硬化症疾病修饰疗法对体外人中性粒细胞功能的抑制作用

Scutera Sara, Musso Tiziana, Cavalla Paola, Piersigilli Giorgia, Sparti Rosaria, Comini Sara, Vercellino Marco, Cuffini Anna Maria, Banche Giuliana, Allizond Valeria